Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HME1 | Alvocidib | 0.001 | 0.9014 | 0.00084 |
| HME1 | Alvocidib | 0.001 | 0.9494 | 0.00318 |
| HME1 | Alvocidib | 0.003162278 | 0.8910 | 0.00236 |
| HME1 | Alvocidib | 0.003162278 | 0.9727 | 0.00926 |
| HME1 | Alvocidib | 0.003162278 | 0.8350 | 0.00457 |
| HME1 | Alvocidib | 0.01 | 0.8245 | 0.03531 |
| HME1 | Alvocidib | 0.01 | 0.9035 | -0.00436 |
| HME1 | Alvocidib | 0.01 | 0.8910 | -0.01333 |
| HME1 | Alvocidib | 0.031622777 | 0.7745 | 0.00889 |
| HME1 | Alvocidib | 0.031622777 | 0.8600 | 0.01932 |
| HME1 | Alvocidib | 0.031622777 | 0.8006 | 0.00028 |
| HME1 | Alvocidib | 0.1 | 0.5420 | 0.05092 |
| HME1 | Alvocidib | 0.1 | 0.5323 | 0.05105 |
| HME1 | Alvocidib | 0.1 | 0.5718 | 0.09150 |
| HME1 | Alvocidib | 0.316227766 | 0.1639 | 0.17164 |
| HME1 | Alvocidib | 0.316227766 | 0.1678 | 0.20700 |
| HME1 | Alvocidib | 0.316227766 | 0.1498 | 0.14881 |
| HME1 | Alvocidib | 1.0 | -0.3044 | 0.53026 |
| HME1 | Alvocidib | 1.0 | -0.3315 | 0.46473 |
| HME1 | Alvocidib | 1.0 | -0.3549 | 0.48322 |
| HME1 | GSK2334470 | 0.001 | 0.9286 | -0.01347 |
| HME1 | GSK2334470 | 0.001 | 1.0135 | -0.00615 |
| HME1 | GSK2334470 | 0.001 | 0.8989 | 0.00266 |
| HME1 | GSK2334470 | 0.003162278 | 1.1347 | -0.01001 |
| HME1 | GSK2334470 | 0.003162278 | 0.9500 | -0.01225 |